Fragmentation Fuels Distrust of Health Sector
The 2026 Edelman Trust Barometer’s Special Report on Health reveals deep fragmentation in U.S. health discourse, with 86% of respondents seeing the sector as divided. Trust in the healthcare system has slipped, and confidence in media reporting on health dropped 18% since 2019, leaving only 38% of Americans believing media messages. Meanwhile, AI adoption for personal health management rose to 35%, and a majority now view AI as capable of matching doctors in treatment decisions. The report urges community engagement and trusted partnerships to mend the trust gap.
Why Are Medical Aid Members Facing More Out-of-Pocket Healthcare Expenses
South African medical scheme members are increasingly hit with out‑of‑pocket costs because schemes reimburse only their own tariff rates while specialists often charge far more, sometimes up to five times the scheme rate. Rising medical inflation—about 9‑10% annually versus 4‑5%...
Mabwell Initiates P-III Trial for 9MW2821 in TNBC
Mabwell has launched a Phase III trial of its Nectin‑4‑targeting antibody‑drug conjugate 9MW2821 in patients with locally advanced or metastatic triple‑negative breast cancer (TNBC). The study pits 9MW2821 against the investigator’s choice of chemotherapy in patients who have already received taxane‑based...
FDA Declines to Approve AbbVie's Botox Follow-Up
The FDA sent a complete response letter to AbbVie, rejecting its filing for TrenibotE, a rapid‑acting, shorter‑duration botulinum toxin intended as a follow‑up to Botox. The agency’s concerns focus on manufacturing data rather than safety or efficacy, and AbbVie says...
The Ron Lanton Report: Where Innovations Happen
Ron Lanton’s latest report argues that geography has become a primary strategic lever in healthcare, shaping where products are developed, manufactured, priced, and sustained. Policy signals, trade dynamics, and infrastructure constraints now sit at the front of the decision tree,...
Therapy Company Mixes Emotional and Artificial Intelligence to Top Ranking
Grow Therapy, founded in 2020, has vaulted to the top of the FT/Statista Fastest‑Growing Companies 2026 list with a 455.6% compound annual growth rate, expanding revenue from $3.6 million in 2021 to $617.4 million in 2024. The company leverages AI‑enhanced chat tools...
The FTC Is Ramping Up to Target Transgender Rights
The Federal Trade Commission has begun treating gender‑affirming care for minors as a consumer‑protection issue, issuing civil investigative demands (CIDs) to leading nonprofits such as the American Academy of Pediatrics, WPATH and the Endocrine Society. The agency hired senior lawyers...
Med Ad News 2026 Industry Person of the Year: Matt McNally
Matt McNally was honored as Med Ad News 2026 Industry Person of the Year, recognizing his impact as global CEO of Publicis Health. Since returning to the firm, he has tightened global connectivity, modernized operating models, and championed creative excellence....
Daiichi Sankyo Postpones Annual Results, Stock Dips
Daiichi Sankyo announced it will postpone the release of its fiscal year 2023 results, pushing the disclosure into early Q2 2024. The company cited the need for additional time to finalize figures amid ongoing regulatory reviews of its oncology pipeline....
Notes & Methodology: Med Ad News 2026 Healthcare Communications Agencies Edition
Med Ad News released its 2026 Healthcare Communications Agencies Edition, outlining strict qualification criteria for inclusion. Agencies must demonstrate capabilities to develop marketing strategies for healthcare professionals, consumers, patients, or payers and hold a significant or growing share of healthcare...
Gut Microbe May Alter Diagnosis, Treatment of Lupus Nephritis
A study in the Annals of Rheumatic Diseases links the gut bacterium Ruminococcus gnavus to active lupus nephritis, showing that its overgrowth triggers platelet and neutrophil activation and kidney infiltration in mouse models. Researchers identified a serum antibody that signals...
FDA Clears First Genetic Hearing Loss Gene Therapy
Regeneron became the first company to receive FDA clearance for a gene therapy targeting congenital hearing loss, approving its OTOF‑focused product Otarmeni. The therapy, an AAV‑delivered one‑shot infusion, will be offered free to U.S. patients, a rare move given typical...
CatalYm Doses First Patient in Phase II/III VINCIT Trial
CatalYm has begun dosing the first patient in its Phase II/III VINCIT trial, evaluating the anti‑GDF‑15 antibody visugromab for cancer‑associated cachexia. The double‑blind, placebo‑controlled study plans to enroll about 518 participants with advanced solid tumours such as NSCLC and colorectal cancer....
Cumberland to Sell Drug Portfolio to Apotex for $100m
Cumberland Pharmaceuticals has agreed to sell its branded commercial drug portfolio to Canadian generic giant Apotex for $100 million in cash, subject to shareholder approval. The transaction lets Cumberland retain its pipeline assets, including the thromboxane antagonist ifetroban, and its majority...
Heat Waves and Cold Waves Are Increasing Cardiovascular Events, Analyses Show
A geospatial analysis of over eight million residents in Eastern Poland found that both heat waves and cold waves significantly raise major adverse cardiovascular and cerebrovascular events (MACCE). Heat waves trigger an immediate 7.5% rise in MACCE and a 9.5%...
Nanoengineered Micellar Hydrogel with Controllable Strain‐Dependent Behavior for Brain Slice‐Like Tissue Patch Bioprinting
Researchers have created a nanoengineered chitosan micelle‑crosslinked hydrogel (CDP) that can be tuned to three distinct rheological states for extrusion‑based bioprinting. By balancing dynamic covalent crosslinks with shear‑induced micelle stacking, the CDP‑II formulation tolerates up to 200% strain while maintaining...
The Royal Marsden Launches World’s First Fully Integrated Multiple Myeloma Patient Pathway
The Royal Marsden has unveiled MyTrack™ Myeloma, the world’s first fully integrated patient pathway for multiple myeloma, merging cutting‑edge diagnostics with specialist clinical input. The service combines SKY92 gene‑expression profiling, clonoSEQ next‑generation sequencing for measurable residual disease, and the EXENT...
Is Stem Cell Therapy About to Transform Medicine and Reverse Ageing?
Stem cell therapy is re‑emerging as a credible route to tissue regeneration and age‑reversal after a decade of failed anti‑ageing bets. Researchers are now demonstrating partial cellular reprogramming that restores youthful function without erasing cell identity. Early‑stage human trials from...
Health-Care AI Is Here. We Don’t Know if It Actually Helps Patients.
Healthcare providers are rapidly integrating AI tools such as ambient scribes and predictive analytics into clinical workflows. Early studies suggest these systems can reduce clinician burnout and speed up tasks, but researchers like Jenna Wiens and Anna Goldenberg warn that evidence linking...
Readers Chime In on Reproductive Rights, Therapy Chatbots, Medical Debt, and More
The letters to the editor published by KFF Health News raise a spectrum of pressing health policy concerns. In Michigan, urgent‑care clinics are stepping in to provide abortion services, exposing the strain on rural health systems already facing a projected...
Suicide Rates Have Declined Since the Launch of 988 Suicide Hotline, Study Finds
A new JAMA study finds that suicide deaths among Americans aged 15 to 34 fell 11%—about 4,300 fewer lives—between the launch of the 988 National Suicide & Crisis Lifeline in July 2022 and December 2024. The decline was most pronounced...
Adaptability Is Key: The Health Squad in Durham Uses Health Diagnostics’ Flexible Software to Tackle CVD and Health Inequality in...
County Durham’s Health Squad, a mobile outreach program partnered with Health Diagnostics, deployed its flexible Health Options® CS platform to deliver physical and mental health checks to 500 vulnerable residents over six months. The software’s configurable dashboards enabled real‑time tracking...
FLEX Vascular Presents 12-Month Real-World Data for FLEX Vessel Prep System at CX Symposium 2026
FLEX Vascular unveiled 12‑month real‑world outcomes from its FLEX FIRST AV Registry at the Charing Cross Symposium 2026. In a cohort of 130 hemodialysis access patients, the FLEX Vessel Prep System showed zero serious adverse events at 30 days and durable...
Re: Health Research in England Is Grinding to a Halt: How Systems Absorb Innovation
A recent BMJ letter argues that health research in England is stagnating because the system absorbs, rather than nurtures, innovation. While the COVID‑19 pandemic demonstrated that rapid ethical approvals, platform trials, and data sharing are feasible, post‑pandemic practices reverted to...
Case Study: Data Sharing Through DECIPHER Supports Rare Disease Research and Clinical Care
The European Genomics Initiative’s DECIPHER platform now hosts data from the University of Bristol’s GenROC study, which has collected clinical and parent‑reported information on nearly 550 children with rare neurodevelopmental disorders. DECIPHER already contains genetic and phenotypic records for more...
Diagonal Therapeutics’ Innovative Clustering Antibodies for Vascular Diseases
Diagonal Therapeutics is advancing a pioneering platform of clustering antibodies designed to restore vascular receptor signaling, targeting the root cause of genetic vasculopathies. Its lead candidate, DIAG723, has earned FDA Orphan Drug Designation for hereditary hemorrhagic telangiectasia (HHT) and shows...
This Week in European MedTech and HealthTech: 24th April 2026
European regulators intensified oversight this week, linking the EU AI Act with the Medical Device Regulation and launching the EU Health Technology Assessment framework, while the first four EUDAMED modules go live in May. Funding activity surged as AI‑driven admin...
Johnson & Johnson Reports Clinical Findings on Imaavy (Nipocalimab) for Generalized Myasthenia Gravis (gMG) at AAN 2026
Johnson & Johnson presented Phase III Vivacity‑MG3 data on its anti‑IgG antibody, Imaavy (nipocalimab), in generalized myasthenia gravis (gMG). In the 24‑week post‑hoc analysis, patients receiving Imaavy plus standard of care were about four times more likely to achieve sustained...
Assisted Dying Bill to Run Out of Time as Lords Hold Final Debate
The Terminally Ill Adults (End of Life) Bill, which would legalise assisted dying for terminally ill adults with less than six months to live, is set to lapse this Friday after stalling in the House of Lords. The Commons approved...
US Department of Health and Human Services Launches $4million National Competition for Innovations in Living Kidney Donation
The U.S. Department of Health and Human Services has launched the KidneyX Empower Challenge, a $4 million national competition aimed at spurring innovations that increase living kidney donation. The contest seeks solutions that improve public awareness, donor identification, eligibility, outcomes and reduce...
Reset Health and East Suffolk and North Essex NHS Foundation Trust Win Multiple HSJ Partnership Awards for Transforming Access to...
Reset Health, together with East Suffolk and North Essex NHS Foundation Trust and Suffolk and North East Essex Integrated Care Board, won two HSJ Partnership Awards for virtual and personalised care. Their integrated digital platform cut specialist obesity waiting times...
Equipment Management Is a Fragmented System in Integrated Hospitals
Hospitals across the United States grapple with fragmented medical equipment management, causing lost devices, delayed repairs, and excess capital spending. Studies reveal that inconsistent inventory tracking contributes to roughly $25.4 billion in wasted supply‑chain costs each year, while nurses can spend...
Regeneron Reports the US FDA Accelerated Approval of Otarmeni (Lunsotogene Parvec-Cwha) in Genetic Hearing Loss
Regeneron’s Otarmeni (lunsotogene parvec‑cwha) received FDA accelerated approval for treating severe to profound sensorineural hearing loss caused by biallelic OTOF gene variants. The therapy, provided free of charge in the U.S., was evaluated in a Phase I/II CHORD trial of...
What Defines Equipment Readiness in Pharmaceutical Production
Equipment readiness is a critical pillar for pharmaceutical manufacturers, ensuring each batch meets strict quality and safety standards. Core elements include regular calibration, thorough sanitization, preventive maintenance, and meticulous documentation. Operator training and real‑time monitoring further safeguard compliance with regulatory...
A 16,000% Problem: Why Workers’ Comp Can’t Get Drug Costs Under Control
Pharmacy costs in workers’ compensation are soaring because many states prohibit the use of contracted pharmacy networks. Without cost‑sharing, injured employees have no incentive to shop around, allowing out‑of‑network dispensers to charge markups exceeding 16,000 % compared with PBM rates. Private‑label...
Compliance-First AI Engineering in Healthcare: Why Platforms Matter More Than Models
In 2025 the healthcare sector spent about $3.7 billion on AI, yet Gartner finds roughly 75 % of pilots never reach production. Piyoosh Rai argues the chief obstacle is not model accuracy but the absence of robust deployment platforms that guarantee compliance,...
Opinion: Prasad’s FDA Exit Good for Rare Diseases but New CBER Head Must Repair Eroded Trust
Vinay Prasad’s exit from the FDA’s Center for Biologics Evaluation and Research (CBER) follows a Senate hearing that highlighted inconsistent approval pathways for rare‑disease therapies. Industry sponsors and patient advocates complained that the agency reversed previously negotiated trial designs, leaving patients...
What Trump’s Psychedelics Executive Order Means for Basic Neuroscience
President Donald Trump issued an executive order to accelerate clinical research on psychedelic drugs, allocating at least $50 million for state‑run programs and directing the FDA to speed up drug reviews. The order also tasks the attorney general with reviewing the...
AI Not 'Economically Viable' If It Doesn't Replace at Least some Radiologists, Experts Claim
Experts argue that artificial intelligence will only be economically viable in radiology if it replaces a portion of the radiology workforce. While AI is marketed as an augmentative tool, its true financial value lies in labor substitution and operational efficiency....
Teenage Mono Infection Linked to Higher Risk of Multiple Sclerosis Later in Life
A new long‑term study linking teenage infectious mononucleosis to a three‑fold increase in multiple sclerosis risk was conducted by researchers at Moderna and the Mayo Clinic using Rochester Epidemiology Project data. The analysis covered over two decades of health records,...
Regulatory Review: Andrographis, Caffeine Warning, Biotics and More
Regulators across several markets are tightening rules for dietary supplements and natural health products. Australia’s TGA is consulting on removing Andrographis from its low‑risk ingredient list after anaphylaxis reports, while the EU continues to block probiotic health claims and has...
How Phoenix Rebellion Therapy Approaches Depression Therapy in Salt Lake City
Phoenix Rebellion Therapy in Salt Lake City delivers comprehensive depression treatment for adults and adolescents, beginning with a thorough assessment and an individualized, evidence‑based plan. The practice blends cognitive‑behavioral strategies, emotion‑focused work, trauma‑informed care, and medication when appropriate. It also...
When to Consider Cosmetic Dentistry and Why It Works
Cosmetic dentistry is increasingly popular for its dual promise of a brighter smile and functional oral improvements. Treatments such as professional whitening, veneers, and alignment address stubborn stains, chipped teeth, and minor bite issues while boosting confidence. Successful outcomes depend...
'Sterility Failures' Prompt FDA to Threaten Radiopharmaceutical Producer with Disciplinary Action
The FDA issued a warning letter to the University of California San Francisco Radiopharmaceutical Facility after sterility testing uncovered Bacillus contamination in a PET‑imaging agent batch. The agency found the facility’s explanation—that the bacteria entered the test tube during analysis—insufficient...
Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading
A new American Medical Association report shows physician burnout modestly improving, with 41.9% reporting at least one symptom in 2025, down from 48.2% in 2023. Emergency medicine remains the most affected specialty at 49.8%, followed closely by urological surgery. The...
Why Carpet Disinfectant Is Critical for Infection Control in Healthcare Facilities
Carpet surfaces in hospitals and clinics can harbor bacteria, viruses, and other pathogens deep within their fibers, turning them into hidden reservoirs of infection. While routine cleaning removes visible dirt, it does not reliably eliminate these microorganisms, making disinfection a...
Largest Catch-Up Initiative Delivers over 100 Million Childhood Vaccinations
The Big Catch‑Up (BCU) initiative, launched during World Immunization Week 2023, has administered more than 100 million vaccine doses to an estimated 18.3 million children in 36 low‑ and middle‑income countries. About 12.3 million of those children were zero‑dose, never having received any...
New Bioreactor Turns Stem Cells Into an Immune-Cell Factory, Producing 40 Million Human Macrophages per Week
Researchers at Hannover Medical School have unveiled a medium‑scale bioreactor that converts induced pluripotent stem cells into human macrophages at commercial‑grade volumes. The system can harvest up to 40 million immune cells per bioreactor each week for up to ten weeks,...
SCAN CEO Urges Brokers to Drop Plans That Treat Them Poorly — One Says She Has No Choice
At the Medicarians Conference, SCAN Health Plan CEO Sachin Jain urged brokers to abandon for‑profit Medicare Advantage plans that cut commissions and instead partner with not‑for‑profit carriers. He framed the plea as self‑interest, noting the recent 2.48% Medicare Advantage rate...
![[Comment] Alzheimer's Disease Immunotherapy and the Amyloid Hypothesis: When Aggregation Obscures Interpretation](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/614bb5987569a37ee2c14e1338f7df10.webp)
[Comment] Alzheimer's Disease Immunotherapy and the Amyloid Hypothesis: When Aggregation Obscures Interpretation
A Cochrane review released on April 16, 2026 pooled data from 17 randomized trials of amyloid‑beta‑targeting monoclonal antibodies, encompassing more than 20,000 participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The analysis found little to no...